GTC Biotherapeutics Inc. expects to raise $15 million by selling 6.4 million shares of its common stock at $2.34 per share. (BioWorld Today)

GTC Biotherapeutics Inc. expects to raise $15 million by selling 6.4 million shares of its common stock at $2.34 per share. (BioWorld Today)

Gilead Sciences Inc. is requesting FDA approval of a co-formulation combining Viread with Emtriva in a single pill dosed once daily to be taken with other antiretrovirals for the treatment of HIV. (BioWorld Today)

Gilead Sciences Inc. is requesting FDA approval of a co-formulation combining Viread with Emtriva in a single pill dosed once daily to be taken with other antiretrovirals for the treatment of HIV. (BioWorld Today)